{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:44:04Z","timestamp":1793727844270,"version":"4.6.1"},"reference-count":42,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T00:00:00Z","timestamp":1698537600000},"content-version":"unspecified","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2023,9,16]]},"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Maternal vaccination is a promising strategy to reduce the burden of vaccine-preventable diseases for mothers and infants. We aimed to provide an up-to-date overview of the efficacy and safety of all available maternal vaccines.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We searched PubMed, Embase, CENTRAL and ClinicalTrials.gov on 1 February 2022, for phase III and IV randomised controlled trials (RCTs) that compared maternal vaccination against any pathogen with placebo or no vaccination. Primary outcomes were laboratory-confirmed or clinically confirmed disease in mothers and infants. Secondary safety outcomes included intrauterine growth restriction, stillbirth, maternal death, preterm birth, congenital malformations and infant death. Random effects meta-analysis were used to calculate pooled risk ratio\u2019s (RR). Quality appraisal was performed using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Six RCTs on four maternal vaccines, influenza, tetanus, diphtheria and pertussis (Tdap), pneumococcal and respiratory syncytial virus (RSV) were eligible. The overall risk of bias and certainty of evidence varied from low to high. Maternal influenza vaccination significantly reduced the number of laboratory-confirmed influenza cases (RR 0.58, 95% CI 0.42 to 0.79, event rate 57 vs 98, 2 RCTs, n=6003, I<jats:sup>2<\/jats:sup>=0%), and clinically confirmed influenza cases in mothers (RR 0.88, 95% CI 0.78 to 0.99, event rate 418 vs 472, 2 RCTs, n=6003, I<jats:sup>2<\/jats:sup>=0%), and laboratory-confirmed influenza in infants (RR 0.66, 95% CI 0.52 to 0.85, event rate 98 vs 148, 2 RCTs, n=5883, I<jats:sup>2<\/jats:sup>=0%), although this was not significant for clinically confirmed influenza in infants (RR 0.99, 95% CI 0.94 to 1.05, event rate 1371 vs 1378, 2 RCTs, n=5883, I<jats:sup>2<\/jats:sup>=0%). No efficacy data were available on maternal Tdap vaccination. Maternal pneumococcal vaccination did not reduce laboratory-confirmed and clinically confirmed middle ear disease (RR 0.49, 95% CI 0.24 to 1.02, event rate 9 vs 18, 1 RCT, n=133\u2009and RR 0.88 95% CI 0.69 to 1.12, event rate 42 vs 47, 1 RCT, n=133, respectively), and clinically confirmed lower-respiratory tract infection (LRTI) (RR 1.08, 95% CI 0.82 to 1.43, event rate 18 vs 34, 1 RCT, n=70) in infants. Maternal RSV vaccination did not reduce laboratory-confirmed RSV LRTI in infants (RR 0.75, 95% CI 0.56 to 1.01, event rate 103 vs 71, 1 RCT, n=4527). There was no evidence of a significant effect of any of the maternal vaccines on the reported safety outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The few RCTs with low event rates suggest that, depending on the type of maternal vaccine, the vaccine might effectively prevent disease and within its size does not show safety concerns in mothers and infants.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PROSPERO registration number<\/jats:title>\n                  <jats:p>CRD42021235115.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjgh-2023-012376","type":"journal-article","created":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T21:15:11Z","timestamp":1698614111000},"page":"e012376","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Are maternal vaccines effective and safe for mothers and infants? A systematic review and meta-analysis of randomised controlled trials"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6295-3411","authenticated-orcid":false,"given":"Odette","family":"de Bruin","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands"},{"name":"Department of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4077-6201","authenticated-orcid":false,"given":"Emily","family":"Phijffer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6261-9445","authenticated-orcid":false,"given":"Fariba","family":"Ahmadizar","sequence":"additional","affiliation":[{"name":"Department of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4793-2724","authenticated-orcid":false,"given":"Nicoline","family":"van der Maas","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3661-551X","authenticated-orcid":false,"given":"Joanne","family":"Wildenbeest","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1360-2388","authenticated-orcid":false,"given":"Miriam","family":"Sturkenboom","sequence":"additional","affiliation":[{"name":"Department of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3099-4475","authenticated-orcid":false,"given":"Louis","family":"Bont","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1377-4625","authenticated-orcid":false,"given":"Kitty","family":"Bloemenkamp","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,10,29]]},"reference":[{"key":"2025072915084852000_8.10.e012376.1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/07853890.2017.1421320","article-title":"Maternal immunization: where are we now and how to move forward","volume":"50","author":"Vojtek","year":"2018","journal-title":"Ann Med"},{"key":"2025072915084852000_8.10.e012376.2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.575197","article-title":"Maternal immunological adaptation during normal pregnancy","volume":"11","author":"Abu-Raya","year":"2020","journal-title":"Front Immunol"},{"key":"2025072915084852000_8.10.e012376.3","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph15050847","article-title":"Maternal vaccination as an essential component of life-course immunization and its contribution to preventive neonatology","volume":"15","author":"Bergin","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"2025072915084852000_8.10.e012376.4","doi-asserted-by":"crossref","DOI":"10.1186\/s12884-017-1559-2","article-title":"Efficacy and safety of pertussis vaccination for pregnant women - a systematic review of randomised controlled trials and observational studies","volume":"17","author":"Furuta","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"2025072915084852000_8.10.e012376.5","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-020-4824-3","article-title":"Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review","volume":"20","author":"Vygen-Bonnet","year":"2020","journal-title":"BMC Infect Dis"},{"key":"2025072915084852000_8.10.e012376.6","doi-asserted-by":"crossref","first-page":"879493","DOI":"10.5402\/2013\/879493","article-title":"Influenza vaccination in pregnant women: a systematic review","volume":"2013","author":"Galvao","year":"2013","journal-title":"ISRN Prev Med"},{"key":"2025072915084852000_8.10.e012376.7","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1345385"},{"key":"2025072915084852000_8.10.e012376.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.12.056"},{"key":"2025072915084852000_8.10.e012376.9","article-title":"Vaccines for preventing influenza in healthy adults","volume":"2","author":"Demicheli","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2025072915084852000_8.10.e012376.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.02.068"},{"key":"2025072915084852000_8.10.e012376.11","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/AOG.0000000000001068","article-title":"Maternal influenza vaccination and risk for congenital malformations a systematic review and meta-analysis","volume":"126","author":"Polyzos","year":"2015","journal-title":"Obstet Gynecol"},{"key":"2025072915084852000_8.10.e012376.12","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.12977"},{"key":"2025072915084852000_8.10.e012376.13","doi-asserted-by":"crossref","first-page":"D20","DOI":"10.1016\/j.vaccine.2012.11.056","article-title":"Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine","volume":"31 Suppl 4","author":"Schrag","year":"2013","journal-title":"Vaccine"},{"key":"2025072915084852000_8.10.e012376.14","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ajog.2021.10.041","article-title":"Maternal vaccination: a review of current evidence and recommendations","volume":"226","author":"Etti","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"2025072915084852000_8.10.e012376.15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.15585\/mmwr.mm7107e3","article-title":"Effectiveness of maternal vaccination with mRNA COVID-19 vaccine during pregnancy against COVID-19-associated hospitalization in infants aged","volume":"71","author":"Halasa","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025072915084852000_8.10.e012376.16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30052-w"},{"key":"2025072915084852000_8.10.e012376.17","doi-asserted-by":"crossref","first-page":"100313","DOI":"10.1016\/j.lanepe.2022.100313","article-title":"Severe COVID-19 in pregnancy is almost exclusively limited to unvaccinated women \u2013 time for policies to change","volume":"13","author":"Engjom","year":"2022","journal-title":"The Lancet Regional Health - Europe"},{"key":"2025072915084852000_8.10.e012376.18","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S1473-3099(22)00291-2","article-title":"Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape","volume":"23","author":"Mazur","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2025072915084852000_8.10.e012376.19","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1016\/j.vaccine.2020.08.056","article-title":"Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in pregnant women and their infants: results from a randomized placebo-controlled phase II trial","volume":"38","author":"Swamy","year":"2020","journal-title":"Vaccine"},{"key":"2025072915084852000_8.10.e012376.20","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2025072915084852000_8.10.e012376.21","doi-asserted-by":"crossref","unstructured":"Higgins JPT , Thomas J , Chandler J , et al . Cochrane handbook for systematic reviews of interventions. Cochrane Handb Syst Rev Interv 2019:1\u2013694. doi:10.1002\/9781119536604","DOI":"10.1002\/9781119536604"},{"key":"2025072915084852000_8.10.e012376.22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s42256-020-00287-7","article-title":"An open source machine learning framework for efficient and transparent systematic reviews","volume":"3","author":"van de Schoot","year":"2021","journal-title":"Nat Mach Intell"},{"key":"2025072915084852000_8.10.e012376.23","unstructured":"Identifying and handling potentially untrustworthy trials in pregnancy and childbirth cochrane reviews. Cochrane Pregnancy and Childbirth. Available: https:\/\/pregnancy.cochrane.org\/news\/identifying-and-handling-potentially-untrustworthy-trials-pregnancy-and-childbirth-cochrane [Accessed 14 Sep 2023]."},{"key":"2025072915084852000_8.10.e012376.24","unstructured":"Sch\u00fcnemann H , Bro\u017cek J , Guyatt G , et al . GRADE handbook. 2013. Available: https:\/\/training.cochrane.org\/resource\/grade-handbook"},{"key":"2025072915084852000_8.10.e012376.25","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1401480","article-title":"Influenza vaccination of pregnant women and protection of their infants","volume":"371","author":"Madhi","year":"2014","journal-title":"N Engl J Med"},{"key":"2025072915084852000_8.10.e012376.26","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1016\/j.vaccine.2019.07.024","article-title":"Trivalent influenza vaccination randomized control trial of pregnant women and adverse fetal outcomes","volume":"37","author":"Sim\u00f5es","year":"2019","journal-title":"Vaccine"},{"key":"2025072915084852000_8.10.e012376.27","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30252-9"},{"key":"2025072915084852000_8.10.e012376.28","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1473-3099(18)30717-5","article-title":"Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial","volume":"19","author":"Barug","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2025072915084852000_8.10.e012376.29","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.vaccine.2019.10.104","article-title":"Impact of tetanus-diphtheria-acellular pertussis immunization during pregnancy on subsequent infant immunization seroresponses: follow-up from a large randomized placebo-controlled trial","volume":"38","author":"Perrett","year":"2020","journal-title":"Vaccine"},{"key":"2025072915084852000_8.10.e012376.30","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.1016\/j.vaccine.2015.10.101","article-title":"Pneumum: impact from a randomised controlled trial of maternal 23-Valent pneumococcal polysaccharide vaccination on middle ear disease amongst indigenous infants, Northern territory, Australia","volume":"33","author":"Binks","year":"2015","journal-title":"Vaccine"},{"key":"2025072915084852000_8.10.e012376.31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s41479-018-0057-2","article-title":"Impact of the 23-valent pneumococcal polysaccharide vaccination in pregnancy against infant acute lower respiratory infections in the Northern territory of Australia","volume":"10","author":"Binks","year":"2018","journal-title":"Pneumonia (Nathan)"},{"key":"2025072915084852000_8.10.e012376.32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/ajo.13002","article-title":"Birth outcomes in aboriginal mother-infant pairs from the Northern territory, Australia, who received 23-valent polysaccharide pneumococcal vaccination during pregnancy, 2006-2011: the pneumum randomised controlled trial","volume":"60","author":"McHugh","year":"2020","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2025072915084852000_8.10.e012376.33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908380"},{"key":"2025072915084852000_8.10.e012376.34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bpobgyn.2021.02.002","article-title":"Vaccines - safety in pregnancy","volume":"76","author":"Arora","year":"2021","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2025072915084852000_8.10.e012376.35","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/irv.12649","article-title":"Optimal timing of influenza vaccine during pregnancy: a systematic review and meta-analysis","volume":"13","author":"Cuningham","year":"2019","journal-title":"Influenza Other Respir Viruses"},{"key":"2025072915084852000_8.10.e012376.36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02423","article-title":"The effect of timing of tetanus-diphtheria-acellular pertussis vaccine administration in pregnancy on the avidity of pertussis antibodies","volume":"10","author":"Abu-Raya","year":"2019","journal-title":"Front Immunol"},{"key":"2025072915084852000_8.10.e012376.37","unstructured":"Immunization schedules for Healthcare professionals. CDC. Available: https:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/index.html [Accessed 8 Dec 2022]."},{"key":"2025072915084852000_8.10.e012376.38","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.vaccine.2021.02.001","article-title":"Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: follow-up of a randomized trial","volume":"39","author":"Martin\u00f3n-Torres","year":"2021","journal-title":"Vaccine"},{"key":"2025072915084852000_8.10.e012376.39","article-title":"Pneumococcal vaccination during pregnancy for preventing infant infection","volume":"1","author":"Chaithongwongwatthana","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2025072915084852000_8.10.e012376.40","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2016.1167602"},{"key":"2025072915084852000_8.10.e012376.41","first-page":"10","article-title":"Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes","volume":"2022","author":"Phijffer","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"2025072915084852000_8.10.e012376.42","unstructured":"NCT02783170 . Safety and Immunogenicity of simultaneous Tdap and IIV in pregnant women; Available: https:\/\/clinicaltrials.gov\/show\/NCT02783170. https:\/\/www.cochranelibrary.com\/central\/doi\/10.1002\/central\/CN-01558556\/full"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2023-012376","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T22:09:00Z","timestamp":1753826940000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2023-012376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10,29]]},"published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1136\/bmjgh-2023-012376"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2023-012376","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}